Young‐Hwa Chung

3.7k total citations
86 papers, 2.8k citations indexed

About

Young‐Hwa Chung is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Young‐Hwa Chung has authored 86 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 39 papers in Hepatology and 27 papers in Molecular Biology. Recurrent topics in Young‐Hwa Chung's work include Liver Disease Diagnosis and Treatment (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers) and Hepatitis B Virus Studies (17 papers). Young‐Hwa Chung is often cited by papers focused on Liver Disease Diagnosis and Treatment (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers) and Hepatitis B Virus Studies (17 papers). Young‐Hwa Chung collaborates with scholars based in South Korea, United States and Thailand. Young‐Hwa Chung's co-authors include Yung Sang Lee, Han Chu Lee, Young‐Suk Lim, Kang Mo Kim, Dong Jin Suh, Sangtaek Oh, Ju Hyun Shim, Danbi Lee, Dong‐Eun Kim and Eunsil Yu and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Young‐Hwa Chung

83 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Young‐Hwa Chung South Korea	33	1.6k	1.4k	660	490	302	86	2.8k
Yasuteru Kondo Japan	29	1.1k 0.7×	1.1k 0.8×	704 1.1×	315 0.6×	393 1.3×	97	2.5k
Hyo-Suk Lee South Korea	28	1.4k 0.9×	1.4k 1.0×	871 1.3×	435 0.9×	564 1.9×	56	3.1k
Keisuke Hamasaki Japan	28	1.0k 0.7×	1.3k 0.9×	744 1.1×	381 0.8×	278 0.9×	66	2.6k
Pedro Majano Spain	31	908 0.6×	1.1k 0.8×	734 1.1×	328 0.7×	240 0.8×	59	2.8k
Hirotoshi Ebinuma Japan	29	1.1k 0.7×	1.2k 0.9×	579 0.9×	364 0.7×	161 0.5×	148	2.8k
Heike Bantel Germany	30	1.2k 0.8×	2.1k 1.5×	732 1.1×	277 0.6×	268 0.9×	77	3.3k
Carlo Fabris Italy	29	1.5k 1.0×	1.7k 1.2×	299 0.5×	430 0.9×	161 0.5×	160	3.0k
Chung Yong Kim South Korea	31	1.2k 0.8×	1.1k 0.8×	526 0.8×	406 0.8×	355 1.2×	85	2.9k
Yoshizumi Shintani Japan	25	2.5k 1.6×	2.6k 1.9×	762 1.2×	311 0.6×	261 0.9×	33	3.6k
Hideyuki Miyoshi Japan	26	1.4k 0.9×	1.9k 1.3×	1.4k 2.1×	794 1.6×	345 1.1×	49	3.9k

Countries citing papers authored by Young‐Hwa Chung

Since Specialization

Citations

This map shows the geographic impact of Young‐Hwa Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young‐Hwa Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young‐Hwa Chung more than expected).

Fields of papers citing papers by Young‐Hwa Chung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young‐Hwa Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young‐Hwa Chung. The network helps show where Young‐Hwa Chung may publish in the future.

Co-authorship network of co-authors of Young‐Hwa Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Young‐Hwa Chung. A scholar is included among the top collaborators of Young‐Hwa Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Young‐Hwa Chung. Young‐Hwa Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kaewpiboon, Chutima, et al.. (2024). Andrographolide targets EGFR to impede epithelial–mesenchymal transition in human breast cancer cells. Journal of Pharmaceutical and Biomedical Analysis. 248. 116267–116267. 1 indexed citations

Choi, Jonggi, Danbi Lee, Ju Hyun Shim, et al.. (2022). The Korean Hepatitis C Virus Care Cascade in a Tertiary Institution: Current Status and Changes in Testing, Link to Care, and Treatment. Gut and Liver. 16(6). 964–975. 5 indexed citations

Kaewpiboon, Chutima, et al.. (2022). Formoxanthone C Inhibits Malignant Tumor Phenotypes of Human A549 Multidrug Resistant-cancer Cells through Signal Transducer and Activator of Transcription 1-Histone Deacetylase 4 Signaling. Journal of Cancer Prevention. 27(2). 112–121. 1 indexed citations

Lim, Ji Hyae, Kyung Won Kim, Yousun Ko, et al.. (2021). The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACE. BMC Cancer. 21(1). 1164–1164. 14 indexed citations

Choi, Won‐Mook, Jonggi Choi, Danbi Lee, et al.. (2020). Regorafenib Versus Nivolumab After Sorafenib Failure: Real‐World Data in Patients With Hepatocellular Carcinoma. Hepatology Communications. 4(7). 1073–1086. 35 indexed citations

Choi, Jonggi, Seungbong Han, Danbi Lee, et al.. (2020). A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinoma. PLoS ONE. 15(11). e0241808–e0241808. 3 indexed citations

Oh, Sangtaek, Jeong Moon, Ho Young Kang, et al.. (2019). CGK062, a small chemical molecule, inhibits cancer upregulated gene 2‑induced oncogenesis through NEK2 and β‑catenin. International Journal of Oncology. 54(4). 1295–1305. 8 indexed citations

Seo, Eun Jin, Jae‐Ho Bae, Eun‐Jung Park, et al.. (2019). Cancer upregulated gene 2 (CUG2), a novel oncogene, promotes stemness-like properties via the NPM1-TGF-β signaling axis. Biochemical and Biophysical Research Communications. 514(4). 1278–1284. 17 indexed citations

An, Jihyun, Ju Hyun Shim, Seungbong Han, et al.. (2018). Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control study. PLoS ONE. 13(3). e0193232–e0193232. 45 indexed citations

10.

Lee, Seung Bum, Kang Mo Kim, Jihyun An, et al.. (2016). Clinical characteristics and potential aetiologies of non‐B non‐C hepatocellular carcinoma in hepatitis B virus endemic area. Liver International. 36(9). 1351–1361. 17 indexed citations

11.

Kim, Su Jin, Suhwan Chang, Eun Hye Park, et al.. (2014). A PAUF-neutralizing antibody targets both carcinoma and endothelial cells to impede pancreatic tumor progression and metastasis. Biochemical and Biophysical Research Communications. 454(1). 144–150. 10 indexed citations

12.

Chao, Yee, Young‐Hwa Chung, Guohong Han, et al.. (2014). The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in A sian patients with hepatocellular carcinoma: Final results of the START trial. International Journal of Cancer. 136(6). 1458–1467. 100 indexed citations

13.

Park, Won Hyung, Young‐Hwa Chung, Jeong A. Kim, et al.. (2013). Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: Focused on the recurrence patterns. Hepatology Research. 43(12). 1304–1312. 33 indexed citations

14.

Jin, Young‐Joo, Young‐Hwa Chung, Jeong A. Kim, et al.. (2012). Factors Predisposing Metastatic Tumor Antigen 1 Overexpression in Hepatitis B Virus Associated Hepatocellular Carcinoma. Digestive Diseases and Sciences. 57(11). 2917–2923. 19 indexed citations

15.

Hwang, Shin, Chul‐Soo Ahn, Gi‐Won Song, et al.. (2010). Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on a. Liver Transplantation. 17(4). 456–465. 25 indexed citations

16.

Cho, Munju, Yongsu Jeong, Young‐Hwa Chung, et al.. (2009). Cardamonin suppresses melanogenesis by inhibition of Wnt/β-catenin signaling. Biochemical and Biophysical Research Communications. 390(3). 500–505. 61 indexed citations

17.

Agthoven, Ton van, et al.. (2008). BCAR3 regulates EGF-induced DNA synthesis in normal human breast MCF-12A cells. Biochemical and Biophysical Research Communications. 375(3). 430–434. 15 indexed citations

18.

Lee, Hyo‐Suk, Young‐Hwa Chung, Kwan Sik Lee, et al.. (2006). A 12-week clevudine therapy showed potent and durable antiviral activity in HBeAg-positive chronic hepatitis B. Hepatology. 43(5). 982–988. 51 indexed citations

19.

Park, Young Hwan, Han Chu Lee, Soo Hyung Ryu, et al.. (2003). Recent increase in antibiotic‐resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea. Journal of Gastroenterology and Hepatology. 18(8). 927–933. 56 indexed citations

20.

Chung, Young‐Hwa & Young Kee Shong. (1993). Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.. PubMed. 88(2). 244–7. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact